A Long-term Extension Study of E2007 in Patients With Refractory Partial Seizures Uncontrolled With Other Anti-Epileptic Drugs (AEDs)

Inclusion Criteria

• •1. Patients who consent to the study entry on their free will before starting any trial-related activities.
• •2. Patients who participated in Study 231 and completed the required evaluation period (10 weeks).
• •3. Patients who are certainly and voluntarily able to participate in this study and record their seizures by themselves or have family members or caregivers (or nurses, if hospitalized) record the seizures. Patients who wish to continue perampanel treatment and necessitate receiving the long- term administration judged by the investigator or sub-investigator.